In the recent publication by Carmona-Bayonas et al,1 imprecise prognostic awareness was associated with a greater interest in low-efficacy cancer treatments. This study underscores the critical role of prognostic awareness in the decision-making process for cancer therapeutics. Interestingly, patients receiving palliative care often hold onto a belief, sometimes quite strong, that a cure is possible, even when faced with their incurable advanced condition and aware of metastases.2-4 The question arises: should we really expect rational decisions in these situations?

A major focus of the discussion is the theoretically inadequate communication process, as pointed out by Carmona-Bayonas et al,1 where provision of vague information without alluding to death was over 2 times more associated with inaccurate perceptions of curability. However, communication does not appear to be the sole issue. This misperception regarding curability can be illuminated through the lens of Elizabeth Kubler-Ross’s stages of grief framework, which offers insight into emotional progression when dealing with serious illnesses. The initial stages of denial, anger, and bargaining may be specifically linked to these inaccurate perceptions. Patients in denial may struggle to fully acknowledge the true extent of their illness, and it is likely that hope serves as a driving force behind their denial.5 In addition, anger and bargaining may emerge as emotional responses to their perceived loss of control over the disease.

Furthermore, it is important to consider the impact of the fourth Kubler-Ross stage, depression, which may be associated with the realization of incurability. Prognosis awareness, characterized by an understanding of the limited treatment options and poor prognosis, was shown by Carmona-Bayonas et al to be related to increased levels of anxiety, depression, and reduced quality of life.1 In contrast, the final stage, acceptance, permits patients, and physicians to collaboratively make mature decisions aligned with patient preferences and values.6

When patients participating in a study are asked, “Do you believe that your disease is curable?” they are faced with the task of choosing between “yes” and “no,” sometimes even assigning percentage probability values. Insights from research in the realm of behavioral economics, particularly the contributions of Daniel Kahneman, reveal that decision-making is not always driven by rationality but is rather shaped by emotional influences.7 Kahneman’s theory of 2 systems suggests that individuals often rely on intuitive and emotional processes rather than strict analytical reasoning when making decisions. Moreover, the exploration of emotions’ role in decision-making, as demonstrated in prior works,8,9 underscores the significance of emotional cues and past experiences in molding personal preferences. Thus, it is reasonable to contemplate that individuals dealing with advanced cancer might be swayed by emotional factors, such as hope and optimism, leading to an overly optimistic perception of potential cure, even when confronted with objective clinical realities.

The incorrect perception of cure in patients with advanced cancer is concerning, as it may lead to unrealistic expectations and inadequate decision making. Understanding the underlying psychological mechanisms behind this incorrect perception can provide valuable insights for improving physician-patient communication and offering more effective emotional support.

Conflict of Interest

The authors indicated no financial relationships.

References

1.

Carmona-Bayonas
A
,
Rodriguez-Gonzalez
A
,
García-García
T
, et al. .
Can oncologists prompt patient prognostic awareness to enhance decision-making? Data from the NEOetic Study
.
Oncologist
.
2023
. https://doi.org/10.1093/oncolo/oyad100

2.

Paiva
CE
,
Teixeira
AC
,
Lourenço
BM
, et al. .
Anticancer treatment goals and prognostic misperceptions among advanced cancer outpatients
.
Int J Environ Res Public Health
.
2022
;
19
(
10
):
6272
-
6282
. https://doi.org/10.3390/IJERPH19106272

3.

Weeks
JC
,
Cook
EF
,
O’Day
SJ
, et al. .
Relationship between cancer patients’ predictions of prognosis and their treatment preferences
.
JAMA
.
1998
;
279
(
21
):
1709
-
1714
.

4.

Weeks
JC
,
Catalano
PJ
,
Cronin
A
, et al. .
Patients’ expectations about effects of chemotherapy for advanced cancer
.
N Engl J Med
.
2012
;
367
(
17
):
1616
-
1625
. https://doi.org/10.1056/NEJMoa1204410

5.

Daneault
S
,
Dion
D
,
Sicotte
C
, et al. .
Hope and noncurative chemotherapies: which affects the other
?
J Clin Oncol
.
2010
;
28
(
13
):
2310
-
2313
. https://doi.org/10.1523/jneurosci.19-13-05473.1999

6.

Hui
D
,
Mo
L
,
Paiva
CE.
The importance of prognostication: impact of prognostic predictions, disclosures, awareness, and acceptance on patient outcomes
.
Curr Treat Options Oncol
.
2021
;
22
(
2
):
12
.

7.

Kahneman
D.
Thinking, Fast and Slow
.
New York
:
Farrar Straus Giroux
;
2013
:
1
499
.

8.

Bechara
A
,
Damasio
H
,
Damasio
AR
,
Lee
GP.
Different contributions of the human amygdala and ventromedial prefrontal cortex to decision-making
.
J Neurosci
.
1999
;
19
(
13
):
5473
-
5481
. https://doi.org/10.1523/jneurosci.19-13-05473.1999

9.

Bechara
A
,
Damasio
H
,
Damasio
AR.
Emotion, decision making and the orbitofrontal cortex
.
Cereb Cortex
.
2000
;
10
(
3
):
295
-
307
.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [email protected].